AF
VTYX

Amalgamated Financial’s Ventyx Biosciences VTYX Stock Holding History

Amalgamated Financial’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$21K Buy
+1,516
New +$20.3K ﹤0.01% 2738

Other funds holding VTYX

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Amalgamated Financial's VTYX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Ventyx Biosciences (VTYX) in Q1 2022: 1,516 shares worth $21K. The stake represents ﹤0.01% of the portfolio and ranks #2738 among its holdings.

55 funds tracked by Wall St. Rank hold VTYX as of Q1 2022.

  • Amalgamated Financial held 1,516 shares of Ventyx Biosciences worth $21K as of Q1 2022.
  • Ventyx Biosciences was a new Amalgamated Financial position in Q1 2022.
  • Ventyx Biosciences made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2738 holding.
  • 55 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.